191 related articles for article (PubMed ID: 18824294)
1. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.
Wu YK; Chen KT; Kuo YB; Huang YS; Chan EC
Cancer Lett; 2009 Jan; 273(2):331-5. PubMed ID: 18824294
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
[TBL] [Abstract][Full Text] [Related]
3. Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival.
Lan CC; Wu YK; Lee CH; Huang YC; Huang CY; Tsai YH; Huang SF; Tsao TC
Jpn J Clin Oncol; 2010 Mar; 40(3):234-40. PubMed ID: 19933689
[TBL] [Abstract][Full Text] [Related]
4. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
Lee WY
Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis.
Warnecke-Eberz U; Baldus SE; Bollschweiler E; Hoelscher AH; Metzger R
Anticancer Res; 2008; 28(3A):1525-9. PubMed ID: 18630507
[TBL] [Abstract][Full Text] [Related]
8. Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.
Liao ND; Chiang TA; Lee WY
Cancer Cytopathol; 2013 Dec; 121(12):695-702. PubMed ID: 23861325
[TBL] [Abstract][Full Text] [Related]
9. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
10. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
Kleinberg L; Flørenes VA; Nesland JM; Davidson B
Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
[TBL] [Abstract][Full Text] [Related]
11. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.
Lu GJ; Shao CJ; Zhang Y; Wei YY; Xie WP; Kong H
Oncotarget; 2017 Jul; 8(30):49217-49223. PubMed ID: 28514746
[TBL] [Abstract][Full Text] [Related]
13. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients.
Aoe K; Hiraki A; Yamazaki K; Nakamura Y; Murakami T; Maeda T; Nishimura M; Sugi K; Ueoka H
Int J Oncol; 2006 Jul; 29(1):65-72. PubMed ID: 16773186
[TBL] [Abstract][Full Text] [Related]
14. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer.
Yie SM; Lou B; Ye SR; He X; Cao M; Xie K; Ye NY; Lin R; Wu SM; Xiao HB; Gao E
Lung Cancer; 2009 Feb; 63(2):284-90. PubMed ID: 18606477
[TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
17. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
Gaspar MJ; De Miguel J; García Díaz JD; Díez M
Anticancer Res; 2008; 28(5B):2947-52. PubMed ID: 19031938
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
Bektemür G; Ozer F; Kanat F; Imecik O
Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
Li YP; Hu CP; Yang HZ
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):608-10. PubMed ID: 15804072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]